According to the search (https://r7.finngen.fi/gene/SLC25A20), genetic variations in SLC25A20 are significantly linked with hypertrophic obstructive cardiomyopathy (odds ratio, OR = 3.4; P = 0.0022), heart failure and hypertrophic cardiomyopathy (odds ratio, OR = 6.1, P = 0.0029), complications following myocardial infarction (OR = 41, P = 0.0049), and nonischemic cardiomyopathy (OR = 49; P = 0.0052). Here, SLC25A20 is linked to nonischemic cardiomyopathy.